????????112 ???????????????????
??? ???: ???????. ??????: ??- ???????????. ??- ????????. ??- ????(???)??????. ???????????. ?? ...
???????????2022 ?????????????????????1 ?? ?? ???. 1.?????????????13 ???????????????????. ???????????????? 2.??????????? ... Archeo Rapport 28 Mesen ? Collector Aquafin - OARTussen 26 maart en 21 december 2012 werd door ADEDE bvba uit Gent (www.adede.com, www.archeo.be) in opdracht van Aquafin een vlakdekkend archeologisch ... Inside the Courts | An Update From Skadden Securities LitigatorsCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any ... Halozyme Therapeutics, Inc. Financial and Investor UpdateCompany's Annual Report on Form 10-K for the year ended December 31, 2024 . This discussion may contain forward-looking statements based ... Form 10-K for Metagenomi INC filed 03/27/2024 - Annual ReportsRegarding concerns about confounding conditions such as ocular, orbital, or periorbital tumors and related treatments like chemotherapy or ... vTv Therapeutics Annual Report 2025 Form 10-K ... - StockLight... Form 10-K. Available Information. We file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, proxy. 8-K - Corbus Pharmaceuticals Holdings, Inc.... Form 10-K. Other than an investor's own internet access charges, we ... Therapeutix, Inc., a biopharmaceutical company focused on the ... FORM 10-K - SEC EDGAR Filings Search Alert - SECDatabaseForm 10-K, our most recent Quarterly Report on Form 10-Q and other filings we make with the SEC from time to time that are incorporated by ... LENZ Therapeutics, Inc.Form 10-K and in subsequent filings Entrada may make with the SEC. In addition, the forward-looking statements included in this press ... united states securities and exchange commission - Cloudfront.netThe Critical Accounting Policies and Significant Judgments and Estimates included in our Annual Report on Form 10-K for the year ended December ... Cabaletta Bio, Inc.entitled ?Risk Factors? in our most recent Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in our ... FORM 10-K - Annual ReportsI have reviewed this Annual Report on Form 10-K of Acrivon Therapeutics, Inc.;. 2. Based on my knowledge, this report does not contain any ...
Autres Cours:
